Fortis Healthcare reported a robust financial performance for the fourth quarter of FY26, demonstrating strong Fortis Healthcare growth. Specifically, consolidated revenues for the quarter surged by 17.8% to reach ₹2,365 crore. Consequently, operating EBITDA rose 22.2% to ₹531 crore, reflecting healthy clinical demand.

Drivers of Fortis Healthcare Growth

Moreover, the core hospital business served as the primary driver of this financial success. Specifically, hospital revenues rose 19% year-on-year in Q4 FY26 to ₹2,023 crore. Additionally, average revenue per occupied bed (ARPOB) improved to ₹2.56 crore during the fourth quarter. Furthermore, the company observed a significant increase in high-end clinical procedures across key specialties. For instance, robotic surgeries witnessed a massive 66% rise during the fiscal year. In addition, radiation therapy volumes grew by 19%. Consequently, the hospital business expanded its high-margin clinical services.

Expansion of Specialized Services and Diagnostics

Importantly, key specialties like cardiac sciences, orthopedics, neurology, gastroenterology, oncology, and renal sciences contributed 62% to total revenues. In particular, renal sciences and orthopedics emerged as key growth areas, recording 22% and 21% growth respectively. Meanwhile, Fortis strengthened its clinical network by adding nearly 500 beds through strategic acquisitions. These acquisitions included People Tree Hospital in Bengaluru and Shrimann Hospital in Jalandhar. Additionally, the company secured a long-term lease for Greater Noida Hospital. Alongside this, the diagnostics business under Agilus Diagnostics delivered steady growth. Specifically, gross revenues for the diagnostics arm increased 11.1% to ₹387 crore in Q4 FY26.

Frequently Asked Questions

Q1: What was the net profit growth of Fortis Healthcare in Q4 FY26?

Fortis Healthcare reported a 44.2% jump in profit after tax to ₹271 crore for the fourth quarter ended March 31, 2026, compared to ₹188 crore in the corresponding quarter of the previous year.

Q2: Which medical specialties drove the revenue growth for Fortis Healthcare?

The top six specialties—including cardiac sciences, orthopedics, neurology, gastroenterology, oncology, and renal sciences—contributed nearly 62% of total hospital revenues, with renal sciences and orthopedics showing the fastest growth.

Q3: How did the diagnostics business perform during the quarter?

Agilus Diagnostics reported an 11.1% year-on-year increase in gross revenues to ₹387 crore in Q4 FY26, supported by robust preventive testing volumes.

Disclaimer: This content is for informational and educational purposes only. It does not constitute medical advice or replace professional judgment. Refer to the latest local and national guidelines for clinical practice.

References

1. Fortis Healthcare Q4 Profit Jumps 44% as Hospital Business Drives FY26 Growth - ETHealthworld


2. Fortis Healthcare PAT jumps 44% in Q4 as EBITDA margins expand; FY26 profit rises 31% - Business Standard